Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 355

1.

Accuracy of an online tool to assess appropriateness for an epilepsy surgery evaluation-A population-based Swedish study.

Lukmanji S, Altura KC, Rydenhag B, Malmgren K, Wiebe S, Jetté N.

Epilepsy Res. 2018 Jun 28;145:140-144. doi: 10.1016/j.eplepsyres.2018.06.014. [Epub ahead of print]

PMID:
30007238
2.

Similar Pharmacokinetics of the Adalimumab (Humira®) Biosimilar BI 695501 Whether Administered via Subcutaneous Autoinjector or Prefilled Syringe (VOLTAIRE®-AI and VOLTAIRE®-TAI): Phase 1, Randomized, Open-Label, Parallel-Group Trials.

Ramael S, Van Hoorick B, Tiessen R, van Iersel T, Moschetti V, Lang B, Sonderegger I, Wiebe S, Liedert B, Jayadeva G.

Rheumatol Ther. 2018 Jun 29. doi: 10.1007/s40744-018-0119-1. [Epub ahead of print]

3.

Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4E.

Aguilar-Valles A, Haji N, De Gregorio D, Matta-Camacho E, Eslamizade MJ, Popic J, Sharma V, Cao R, Rummel C, Tanti A, Wiebe S, Nuñez N, Comai S, Nadon R, Luheshi G, Mechawar N, Turecki G, Lacaille JC, Gobbi G, Sonenberg N.

Nat Commun. 2018 Jun 25;9(1):2459. doi: 10.1038/s41467-018-04883-5.

4.

Prescription trends and psychiatric symptoms following first receipt of one of seven common antiepileptic drugs in general practice.

Josephson CB, Engbers JDT, Jette N, Patten SB, Sajobi TT, Marshall D, Lowerison M, Wiebe S.

Epilepsy Behav. 2018 Jul;84:49-55. doi: 10.1016/j.yebeh.2018.04.012. Epub 2018 May 9.

PMID:
29753294
5.

Pharmacokinetics/Pharmacodynamics of Dabigatran 75 mg Twice Daily in Patients With Nonvalvular Atrial Fibrillation and Severely Impaired Renal Function.

Martin JL, Esmaeili H, Manuel RC, Petrini M, Wiebe S, Maas H.

J Cardiovasc Pharmacol Ther. 2018 Jan 1:1074248418769167. doi: 10.1177/1074248418769167. [Epub ahead of print]

PMID:
29695165
6.

Exacerbation of mycosis fungoides leading to the diagnosis of chronic myelomonocytic leukemia.

Moritz RKC, Metze D, Wiebe S, Kerkhoff A, Berdel WE, Weishaupt C.

JAAD Case Rep. 2018 Mar 6;4(3):270-273. doi: 10.1016/j.jdcr.2017.09.023. eCollection 2018 Apr. No abstract available.

7.

Effects of depression and anxiety on quality of life in five common neurological disorders.

Prisnie JC, Sajobi TT, Wang M, Patten SB, Fiest KM, Bulloch AGM, Pringsheim T, Wiebe S, Jette N.

Gen Hosp Psychiatry. 2018 May - Jun;52:58-63. doi: 10.1016/j.genhosppsych.2018.03.009. Epub 2018 Apr 4.

PMID:
29684713
8.

A longitudinal cohort study on the impact of the clobazam shortage on patients with epilepsy.

Lukmanji S, Sauro KM, Josephson CB, Altura KC, Wiebe S, Jetté N.

Epilepsia. 2018 Feb;59(2):468-478. doi: 10.1111/epi.13974. Epub 2017 Dec 7.

PMID:
29218701
9.

Online tools for individuals with depression and neurologic conditions: A scoping review.

Lukmanji S, Pham T, Blaikie L, Clark C, Jetté N, Wiebe S, Bulloch A, Holroyd-Leduc J, Macrodimitris S, Mackie A, Patten SB.

Neurol Clin Pract. 2017 Aug;7(4):344-353. doi: 10.1212/CPJ.0000000000000365. Review.

PMID:
29185556
10.

The prevalence of anxiety and associated factors in persons with multiple sclerosis.

Pham T, Jetté N, Bulloch AGM, Burton JM, Wiebe S, Patten SB.

Mult Scler Relat Disord. 2018 Jan;19:35-39. doi: 10.1016/j.msard.2017.11.003.

PMID:
29125968
11.

Multiple image x-radiography for functional lung imaging.

Aulakh GK, Mann A, Belev G, Wiebe S, Kuebler WM, Singh B, Chapman D.

Phys Med Biol. 2017 Dec 14;63(1):015009. doi: 10.1088/1361-6560/aa9904.

PMID:
29116051
12.

The Impact of Blamer-softening on Romantic Attachment in Emotionally Focused Couples Therapy.

Burgess Moser M, Johnson SM, Dalgleish TL, Wiebe SA, Tasca GA.

J Marital Fam Ther. 2017 Oct 8. doi: 10.1111/jmft.12284. [Epub ahead of print]

PMID:
28988437
13.

Serotonin reuptake inhibitors and mortality in epilepsy: A linked primary-care cohort study.

Josephson CB, Gonzalez-Izquierdo A, Denaxas S, Fitzpatrick NK, Sajobi TT, Engbers JDT, Patten S, Jette N, Wiebe S.

Epilepsia. 2017 Nov;58(11):2002-2009. doi: 10.1111/epi.13904. Epub 2017 Sep 24.

PMID:
28944447
14.

Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial.

Vancheri C, Kreuter M, Richeldi L, Ryerson CJ, Valeyre D, Grutters JC, Wiebe S, Stansen W, Quaresma M, Stowasser S, Wuyts WA; INJOURNEY Trial Investigators.

Am J Respir Crit Care Med. 2018 Feb 1;197(3):356-363. doi: 10.1164/rccm.201706-1301OC.

PMID:
28889759
15.

Decline in word-finding: The objective cognitive finding most relevant to patients after mesial temporal lobe epilepsy surgery.

Pauli C, de Oliveira Thais MER, Guarnieri R, Schwarzbold ML, Diaz AP, Ben J, Linhares MN, Markowitsch HJ, Wolf P, Wiebe S, Lin K, Walz R.

Epilepsy Behav. 2017 Oct;75:218-224. doi: 10.1016/j.yebeh.2017.08.012. Epub 2017 Sep 1.

PMID:
28867574
16.

Neural Correlates of Response Inhibition in Early Childhood: Evidence From a Go/No-Go Task.

Abdul Rahman A, Carroll DJ, Espy KA, Wiebe SA.

Dev Neuropsychol. 2017;42(5):336-350. doi: 10.1080/87565641.2017.1355917. Epub 2017 Aug 31.

17.

Response shift in parents' assessment of health-related quality of life of children with new-onset epilepsy.

Sajobi TT, Speechley KN, Liang Z, Goodwin SW, Ferro MA, Wiebe S.

Epilepsy Behav. 2017 Oct;75:97-101. doi: 10.1016/j.yebeh.2017.07.015. Epub 2017 Aug 24.

PMID:
28843213
18.

Multivariate trajectories across multiple domains of health-related quality of life in children with new-onset epilepsy.

Sajobi TT, Wang M, Ferro MA, Brobbey A, Goodwin S, Speechley KN, Wiebe S.

Epilepsy Behav. 2017 Oct;75:72-78. doi: 10.1016/j.yebeh.2017.07.037. Epub 2017 Aug 19.

PMID:
28830030
19.

Creating relationships that foster resilience in Emotionally Focused Therapy.

Wiebe SA, Johnson SM.

Curr Opin Psychol. 2017 Feb;13:65-69. doi: 10.1016/j.copsyc.2016.05.001. Epub 2016 May 6. Review.

PMID:
28813297
20.

How long for epilepsy remission in the ILAE definition?

Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, Engel J Jr, Forsgren L, French JA, Hesdorffer DC, Lee BI, Mathern GW, Moshe SL, Perucca E, Scheffer IE, Tomson T, Watanabe M, Wiebe S.

Epilepsia. 2017 Aug;58(8):1486-1487. doi: 10.1111/epi.13821. No abstract available.

PMID:
28799662
21.

Author response: Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies.

Jette N, Fiest KM, Sauro KM, Wiebe S, Patten SB.

Neurology. 2017 Aug 8;89(6):641-642. doi: 10.1212/WNL.0000000000004206. No abstract available.

PMID:
28784639
22.

A meta-analysis on progressive atrophy in intractable temporal lobe epilepsy: Time is brain?

Caciagli L, Bernasconi A, Wiebe S, Koepp MJ, Bernasconi N, Bernhardt BC.

Neurology. 2017 Aug 1;89(5):506-516. doi: 10.1212/WNL.0000000000004176. Epub 2017 Jul 7. Review.

23.

Metastatic triple-negative breast cancer patient with TP53 tumor mutation experienced 11 months progression-free survival on bortezomib monotherapy without adverse events after ending standard treatments with grade 3 adverse events.

Meißner T, Mark A, Williams C, Berdel WE, Wiebe S, Kerkhoff A, Wardelmann E, Gaiser T, Müller-Tidow C, Rosenstiel P, Arnold N, Leyland-Jones B, Franke A, Stanulla M, Forster M.

Cold Spring Harb Mol Case Stud. 2017 Jul 5;3(4). pii: a001677. doi: 10.1101/mcs.a001677. Print 2017 Jul.

24.

Usability testing of a developed assistive robotic system with virtual assistance for individuals with cerebral palsy: a case study.

Jafari N, Adams K, Tavakoli M, Wiebe S, Janz H.

Disabil Rehabil Assist Technol. 2017 Jul 4:1-6. doi: 10.1080/17483107.2017.1344884. [Epub ahead of print]

PMID:
28673115
25.

Integrated genome and transcriptome sequencing identifies a noncoding mutation in the genome replication factor DONSON as the cause of microcephaly-micromelia syndrome.

Evrony GD, Cordero DR, Shen J, Partlow JN, Yu TW, Rodin RE, Hill RS, Coulter ME, Lam AN, Jayaraman D, Gerrelli D, Diaz DG, Santos C, Morrison V, Galli A, Tschulena U, Wiemann S, Martel MJ, Spooner B, Ryu SC, Elhosary PC, Richardson JM, Tierney D, Robinson CA, Chibbar R, Diudea D, Folkerth R, Wiebe S, Barkovich AJ, Mochida GH, Irvine J, Lemire EG, Blakley P, Walsh CA.

Genome Res. 2017 Aug;27(8):1323-1335. doi: 10.1101/gr.219899.116. Epub 2017 Jun 19.

26.

The prevalence of anxiety and associated factors in persons with epilepsy.

Pham T, Sauro KM, Patten SB, Wiebe S, Fiest KM, Bulloch AGM, Jetté N.

Epilepsia. 2017 Aug;58(8):e107-e110. doi: 10.1111/epi.13817. Epub 2017 Jun 9.

PMID:
28597927
27.

Precision of pQCT-measured total, trabecular and cortical bone area, content, density and estimated bone strength in children.

Duff WRD, Björkman KM, Kawalilak CE, Kehrig AM, Wiebe S, Kontulainen S.

J Musculoskelet Neuronal Interact. 2017 Jun 1;17(2):59-68.

28.

Metformin ameliorates core deficits in a mouse model of fragile X syndrome.

Gantois I, Khoutorsky A, Popic J, Aguilar-Valles A, Freemantle E, Cao R, Sharma V, Pooters T, Nagpal A, Skalecka A, Truong VT, Wiebe S, Groves IA, Jafarnejad SM, Chapat C, McCullagh EA, Gamache K, Nader K, Lacaille JC, Gkogkas CG, Sonenberg N.

Nat Med. 2017 Jun;23(6):674-677. doi: 10.1038/nm.4335. Epub 2017 May 15.

PMID:
28504725
29.

Proactive control in early and middle childhood: An ERP study.

Elke S, Wiebe SA.

Dev Cogn Neurosci. 2017 Aug;26:28-38. doi: 10.1016/j.dcn.2017.04.005. Epub 2017 Apr 14.

30.

Mind the gap: Exploring information gaps for the development of an online resource hub for epilepsy and depression.

Crooks RE, Bell M, Patten SB, Wiebe S, Holroyd-Leduc J, Bulloch AG, Macrodimitris S, Mackie A, Sauro KM, Federico P, Jetté N.

Epilepsy Behav. 2017 May;70(Pt A):18-23. doi: 10.1016/j.yebeh.2017.03.005. Epub 2017 Apr 10.

PMID:
28407525
31.

Derivation and initial validation of a surgical grading scale for the preliminary evaluation of adult patients with drug-resistant focal epilepsy.

Dugan P, Carlson C, Jetté N, Wiebe S, Bunch M, Kuzniecky R, French J.

Epilepsia. 2017 May;58(5):792-800. doi: 10.1111/epi.13730. Epub 2017 Apr 4.

32.

Predictors of meaningful improvement in quality of life after temporal lobe epilepsy surgery: A prospective study.

Pauli C, Schwarzbold ML, Diaz AP, de Oliveira Thais MER, Kondageski C, Linhares MN, Guarnieri R, de Lemos Zingano B, Ben J, Nunes JC, Markowitsch HJ, Wolf P, Wiebe S, Lin K, Walz R.

Epilepsia. 2017 May;58(5):755-763. doi: 10.1111/epi.13721. Epub 2017 Mar 23.

33.

Lumbar Fusion for Degenerative Disease: A Systematic Review and Meta-Analysis.

Yavin D, Casha S, Wiebe S, Feasby TE, Clark C, Isaacs A, Holroyd-Leduc J, Hurlbert RJ, Quan H, Nataraj A, Sutherland GR, Jette N.

Neurosurgery. 2017 May 1;80(5):701-715. doi: 10.1093/neuros/nyw162. Review.

PMID:
28327997
34.

ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology.

Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, Hirsch E, Jain S, Mathern GW, Moshé SL, Nordli DR, Perucca E, Tomson T, Wiebe S, Zhang YH, Zuberi SM.

Epilepsia. 2017 Apr;58(4):512-521. doi: 10.1111/epi.13709. Epub 2017 Mar 8.

35.

Association of Depression and Treated Depression With Epilepsy and Seizure Outcomes: A Multicohort Analysis.

Josephson CB, Lowerison M, Vallerand I, Sajobi TT, Patten S, Jette N, Wiebe S.

JAMA Neurol. 2017 May 1;74(5):533-539. doi: 10.1001/jamaneurol.2016.5042.

36.

Validation of a Case Definition for Pediatric Brain Injury Using Administrative Data.

McChesney-Corbeil J, Barlow K, Quan H, Chen G, Wiebe S, Jette N.

Can J Neurol Sci. 2017 Mar;44(2):161-169. doi: 10.1017/cjn.2016.419. Epub 2017 Jan 20.

PMID:
28103959
37.

Depression screening tools in persons with epilepsy: A systematic review of validated tools.

Gill SJ, Lukmanji S, Fiest KM, Patten SB, Wiebe S, Jetté N.

Epilepsia. 2017 May;58(5):695-705. doi: 10.1111/epi.13651. Epub 2017 Jan 8. Review.

38.

Two-Year Follow-up Outcomes in Emotionally Focused Couple Therapy: An Investigation of Relationship Satisfaction and Attachment Trajectories.

Wiebe SA, Johnson SM, Lafontaine MF, Burgess Moser M, Dalgleish TL, Tasca GA.

J Marital Fam Ther. 2017 Apr;43(2):227-244. doi: 10.1111/jmft.12206. Epub 2016 Dec 20.

PMID:
27997704
39.

Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies.

Fiest KM, Sauro KM, Wiebe S, Patten SB, Kwon CS, Dykeman J, Pringsheim T, Lorenzetti DL, Jetté N.

Neurology. 2017 Jan 17;88(3):296-303. doi: 10.1212/WNL.0000000000003509. Epub 2016 Dec 16. Review. Erratum in: Neurology. 2017 Aug 8;89(6):642.

40.

III. DISTINGUISHING EXECUTIVE CONTROL FROM OVERLAPPING FOUNDATIONAL COGNITIVE ABILITIES DURING THE PRESCHOOL PERIOD.

Nelson JM, James TD, Choi HJ, Clark CA, Wiebe SA, Espy KA.

Monogr Soc Res Child Dev. 2016 Dec;81(4):47-68. doi: 10.1111/mono.12270. No abstract available.

PMID:
27943324
41.

II. THE PRESCHOOL PROBLEM SOLVING STUDY: SAMPLE, DATA, AND STATISTICAL METHODS.

James TD, Choi HJ, Wiebe SA, Espy KA.

Monogr Soc Res Child Dev. 2016 Dec;81(4):30-46. doi: 10.1111/mono.12269. No abstract available.

PMID:
27943320
42.

Predicting Follow-up Outcomes in Emotionally Focused Couple Therapy: The Role of Change in Trust, Relationship-Specific Attachment, and Emotional Engagement.

Wiebe SA, Johnson SM, Burgess Moser M, Dalgleish TL, Tasca GA.

J Marital Fam Ther. 2017 Apr;43(2):213-226. doi: 10.1111/jmft.12199. Epub 2016 Nov 22.

PMID:
27874215
43.

Quality indicators for the adult epilepsy monitoring unit.

Sauro KM, Wiebe S, Macrodimitris S, Jetté N; EMU Quality Improvement Team.

Epilepsia. 2016 Nov;57(11):1771-1778. doi: 10.1111/epi.13563. Epub 2016 Oct 10. Review.

44.

A Phase I Dose Escalation Study of the Triple Angiokinase Inhibitor Nintedanib Combined with Low-Dose Cytarabine in Elderly Patients with Acute Myeloid Leukemia.

Schliemann C, Gerss J, Wiebe S, Mikesch JH, Knoblauch N, Sauer T, Angenendt L, Kewitz T, Urban M, Butterfass-Bahloul T, Edemir S, Vehring K, Müller-Tidow C, Berdel WE, Krug U.

PLoS One. 2016 Oct 7;11(10):e0164499. doi: 10.1371/journal.pone.0164499. eCollection 2016.

45.

Quality and safety in adult epilepsy monitoring units: A systematic review and meta-analysis.

Sauro KM, Wiebe N, Macrodimitris S, Wiebe S, Lukmanji S, Jetté N.

Epilepsia. 2016 Nov;57(11):1754-1770. doi: 10.1111/epi.13564. Epub 2016 Oct 7. Review.

46.

Knowledge translation of an online tool to determine candidacy for epilepsy surgery evaluation.

Sauro KM, Holroyd-Leduc J, Wiebe S, Quan H, Cooke L, Cross JH, Mathern GW, Armson H, Stromer J, Jetté N.

Neurol Clin Pract. 2016 Aug;6(4):304-314.

47.

Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic Leukemia.

Lutz M, Schulze AB, Rebber E, Wiebe S, Zoubi T, Grauer OM, Keßler T, Kerkhoff A, Lenz G, Berdel WE.

Cancer Res Treat. 2017 Apr;49(2):548-552. doi: 10.4143/crt.2016.110. Epub 2016 Jul 12.

48.

Not all that glitters is gold: A guide to the critical interpretation of drug trials in epilepsy.

Perucca E, Wiebe S.

Epilepsia Open. 2016 Jul 27;1(1-2):9-21. doi: 10.1002/epi4.3. eCollection 2016 Sep. Review.

49.

Influence of Renal Impairment on the Pharmacokinetics of Afatinib: An Open-Label, Single-Dose Study.

Wiebe S, Schnell D, Külzer R, Gansser D, Weber A, Wallenstein G, Halabi A, Conrad A, Wind S.

Eur J Drug Metab Pharmacokinet. 2017 Jun;42(3):461-469. doi: 10.1007/s13318-016-0359-9.

50.

An HIV-tailored quit-smoking counselling pilot intervention targeting depressive symptoms plus Nicotine Replacement Therapy.

Balfour L, Wiebe SA, Cameron WD, Sandre D, Pipe A, Cooper C, Angel J, Garber G, Holly C, Dalgleish TL, Tasca GA, MacPherson PA.

AIDS Care. 2017 Jan;29(1):24-31. Epub 2016 Jul 19.

PMID:
27435835

Supplemental Content

Support Center